Jifu Wei[Author] - Search Results

Year	Number of Results
2002	6
2003	2
2004	1
2005	4
2006	4
2007	2
2008	3
2009	8
2010	9
2012	7
2013	9
2014	11
2015	8
2016	8
2017	22
2018	15
2019	18
2020	15
2021	16
2022	25
2023	13
2024	5

1

The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer.

Wang JZ, Zhu W, Han J, Yang X, Zhou R, Lu HC, Yu H, Yuan WB, Li PC, Tao J, Lu Q, Wei JF, Yang H. Wang JZ, et al. Cancer Commun (Lond). 2021 Jul;41(7):560-575. doi: 10.1002/cac2.12158. Epub 2021 May 15. Cancer Commun (Lond). 2021. PMID: 33991457 Free PMC article.

2

CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application.

Yang YH, Liu JW, Lu C, Wei JF. Yang YH, et al. Int J Biol Sci. 2022 Mar 21;18(6):2609-2626. doi: 10.7150/ijbs.70120. eCollection 2022. Int J Biol Sci. 2022. PMID: 35414783 Free PMC article. Review.

3

METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.

Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, Wei JF, Yang H. Han J, et al. Mol Cancer. 2019 Jun 22;18(1):110. doi: 10.1186/s12943-019-1036-9. Mol Cancer. 2019. PMID: 31228940 Free PMC article.

4

Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-Analysis.

Zhao M, Pan X, Yin Y, Hu H, Wei J, Bai Z, Tang W. Zhao M, et al. Among authors: wei j. Front Public Health. 2022 Apr 15;10:869960. doi: 10.3389/fpubh.2022.869960. eCollection 2022. Front Public Health. 2022. PMID: 35493395 Free PMC article.

5

Protein Drugs Related to Allergic Reaction.

Wei JF, Xu TR, Yu MC, Zhou XD, Zhao ZT, Jin Y. Wei JF, et al. Biomed Res Int. 2015;2015:614048. doi: 10.1155/2015/614048. Epub 2015 May 11. Biomed Res Int. 2015. PMID: 26078957 Free PMC article. No abstract available.

6

Detection of N6‑methyladenosine modification residues (Review).

Zhu W, Wang JZ, Xu Z, Cao M, Hu Q, Pan C, Guo M, Wei JF, Yang H. Zhu W, et al. Int J Mol Med. 2019 Jun;43(6):2267-2278. doi: 10.3892/ijmm.2019.4169. Epub 2019 Apr 18. Int J Mol Med. 2019. PMID: 31017262 Free PMC article. Review.

7

The Effects of Genetic Polymorphisms in Pharmacokinetics and Pharmacodynamics Parameters.

Wei JF. Wei JF. Curr Drug Metab. 2018;19(14):1140. doi: 10.2174/138920021914181211113837. Curr Drug Metab. 2018. PMID: 30600790

8

Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity.

Cai M, Zhao J, Ding Q, Wei J. Cai M, et al. Among authors: wei j. Heliyon. 2024 Jan 10;10(2):e24454. doi: 10.1016/j.heliyon.2024.e24454. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38293535 Free PMC article. Review.

9

Tryptase inhibitors: a patent review.

Ni WW, Cao MD, Huang W, Meng L, Wei JF. Ni WW, et al. Expert Opin Ther Pat. 2017 Aug;27(8):919-928. doi: 10.1080/13543776.2017.1322064. Epub 2017 May 3. Expert Opin Ther Pat. 2017. PMID: 28425830 Review.

10

α₄β₇ integrin inhibitors: a patent review.

Li H, Huang SY, Shi FH, Gu ZC, Zhang SG, Wei JF. Li H, et al. Expert Opin Ther Pat. 2018 Dec;28(12):903-917. doi: 10.1080/13543776.2018.1549227. Epub 2018 Nov 22. Expert Opin Ther Pat. 2018. PMID: 30444683 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

184 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Results by year